BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the first patient has been dosed with exidavnemab in the EXIST Phase 2a study, in Parkinson's disease patients. Exidavnemab is a ...
Director of public prosecutions Stephen Parkinson sets out plan to tackle crisis as massive rise in rape victim ‘attrition ...
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
The Killeen Police Department is investigating a shooting that left two people injured.Officers are currently conducting the ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...